Results 131 to 140 of about 248,209 (312)

Trends in Intention to Take the Second Booster COVID-19 Vaccination and Associated Factors in China: Serial Cross-Sectional Surveys [PDF]

Background: The escalating complexity of the COVID-19 epidemic underscores the need for heightened attention to booster vaccinations. This study aims to examine the changing trend in the public’s intention to receive the second COVID-19 booster ...
Xu Wang, Yihan Tang, Jing Gu, Yu Ma, Jinghua Li, Zhiwei Wang, Ziying Yang, Zhoubin Zhang, Lingyu Kong   +8 more
core   +1 more source

Association between vaccination beliefs and COVID-19 vaccine uptake in a longitudinal panel survey of adults in the United States, 2021–2022

Vaccine: X
COVID-19 vaccine hesitancy has been a major limiting factor to the widespread uptake of COVID-19 vaccination in the United States. A range of interventions, including mass media campaigns, have been implemented to encourage COVID-19 vaccine confidence ...
Elissa C. Kranzler, Joseph N. Luchman, Katherine A. Margolis, Timothy O. Ihongbe, Jae-Eun C. Kim, Benjamin Denison, Victor Vuong, Blake Hoffman, Heather Dahlen, Kathleen Yu, Daphney Dupervil, Leah Hoffman   +11 more
doaj   +1 more source

The COVID-19 vaccination

Medicina Clínica (English Edition), 2021
Casas, Irma, Mena, Guillermo
openaire   +4 more sources

Covid-19 vaccines for kids

New Scientist, 2021
Early trial results hint that vaccines could be safe for children, but how the virus behaves will determine their roll-out, reports Helen Thomson.
openaire   +2 more sources

Comparable Infection Risk of Ocrelizumab and Rituximab in Multiple Sclerosis in a Nationwide Swedish Cohort Study

Annals of Neurology, EarlyView.
In multiple sclerosis (MS), anti‐CD20 therapies have been associated with increased infection risk, but whether this risk differs between rituximab and ocrelizumab is not known. Using a nationwide cohort, we studied infection risk and relapse outcomes among 16,872 treatment episodes with rituximab, ocrelizumab, or other disease‐modifying therapies ...
Thomas Frisell, Sebastian Hedberg, Fredrik Piehl   +2 more
wiley   +1 more source

[COVID-19 vaccine safety].

Revista peruana de medicina experimental y salud publica, 2021
The development and production of safe and effective vaccines against coronavirus disease 2019 (COVID-19) provides hope for controlling the current pandemic. Adverse events following immunization are unwanted responses or unintended events that must be carefully monitored, as all vaccines, including those developed against SARS-CoV-2, are required to ...
Nataniel Aldo Chaparro Mérida, Dayany Moreno Samper, Alex Omar Franco Lacato   +2 more
openaire   +2 more sources

Chicken Pulmonary MicroRNAs Targeting the PB2 (Segment 1) of Avian Influenza Virus

Animal Research and One Health, EarlyView.
The PB2 segment of H5N1 is essential for replication and host adaptation. We screened 200 miRNAs and identified five (gga‐miR‐17‐3p, gga‐miR‐29a‐5p, gga‐miR‐1718, gga‐miR‐16c‐5p, and gga‐miR‐1744‐5p) using thermodynamic stability of heteroduplex, seed sequence complementarity, conservation, and accessibility, offering insights into host antiviral ...
Akanksha Choudhary, Nidhishree N. S, Rakesh Kumar Pundir, Muhasin Asaf V. N, Anamika Mishra, Ashwin Ashok Raut, Megha Agarwal, Amod Kumar   +7 more
wiley   +1 more source

Differences in SARS‐CoV‐2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER‐Adult Cohort Study

Arthritis &Rheumatology, EarlyView.
Objective Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post–acute COVID‐19 outcomes, though whether individuals with SARDs have longer persistence of viral antigens after COVID‐19 has not been studied.
Naomi J. Patel, Zoe Swank, Jiaqi Wang, Xiaosong Wang, Lauren A. O'Keeffe, Madison Negron, Liya S. Getachew, Louise L. Hansen, Grace Qian, Alene A. Saavedra, Kevin T. Mueller, Natalie A. Davis, Kathleen M. M. Vanni, Sandria Savage, Julie S. Lam, Zachary S. Wallace, David R. Walt, Jeffrey A. Sparks, on behalf of RECOVER‐Adult   +18 more
wiley   +1 more source

Developing a critical caste analysis within information science and technology: A research review: An Annual Review of Information Science and Technology (ARIST) paper

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Caste—an ascriptive social hierarchy in South Asia and its diaspora—is a globalized phenomenon. Recent caste‐based discrimination, particularly in technology companies and anti‐caste efforts to address it, has compelled academia, policy, and the technology industry to better understand contemporary mechanics of caste.
Nayana Kirasur, Britt Paris
wiley   +1 more source

Toward ‘Vaccine Internationalism’: The Need for an Equitable and Coordinated Global Vaccination Approach to Effectively Combat COVID-19

International Journal of Public Health, 2021
Brian L. H. Wong, Brian L. H. Wong, Manfred S. Green, Manfred S. Green, John Reid, John Reid, Jose M. Martin-Moreno, Jose M. Martin-Moreno, Jose M. Martin-Moreno, Nadav Davidovitch, Nadav Davidovitch, Laurent Chambaud, Laurent Chambaud, Lore Leighton, Mohamud Sheek-Hussein, Mohamud Sheek-Hussein, Ranjeet Dhonkal, Ranjeet Dhonkal, Robert Otok, John D. Middleton, John D. Middleton   +20 more
doaj   +1 more source